- Home
- KN vs BEAM Comparison
KN vs BEAM Comparison
Compare KN & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KN
- BEAM
- Stock Information
- Founded
- KN 1946
- BEAM 2017
- Country
- KN United States
- BEAM United States
- Employees
- KN N/A
- BEAM N/A
- Industry
- KN Consumer Electronics/Appliances
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KN Consumer Staples
- BEAM Health Care
- Exchange
- KN Nasdaq
- BEAM Nasdaq
- Market Cap
- KN 1.7B
- BEAM 1.9B
- IPO Year
- KN N/A
- BEAM 2020
- Fundamental
- Price
- KN $19.41
- BEAM $29.01
- Analyst Decision
- KN Hold
- BEAM Buy
- Analyst Count
- KN 1
- BEAM 10
- Target Price
- KN $19.00
- BEAM $47.67
- AVG Volume (30 Days)
- KN 766.4K
- BEAM 1.2M
- Earning Date
- KN 02-05-2025
- BEAM 11-05-2024
- Dividend Yield
- KN N/A
- BEAM N/A
- EPS Growth
- KN N/A
- BEAM N/A
- EPS
- KN N/A
- BEAM N/A
- Revenue
- KN $801,000,000.00
- BEAM $349,643,000.00
- Revenue This Year
- KN $0.38
- BEAM N/A
- Revenue Next Year
- KN N/A
- BEAM $10.82
- P/E Ratio
- KN $37.38
- BEAM N/A
- Revenue Growth
- KN 55.62
- BEAM 328.73
- 52 Week Low
- KN $14.97
- BEAM $20.84
- 52 Week High
- KN $20.49
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- KN 51.92
- BEAM 56.94
- Support Level
- KN $19.06
- BEAM $24.96
- Resistance Level
- KN $20.49
- BEAM $29.53
- Average True Range (ATR)
- KN 0.48
- BEAM 2.05
- MACD
- KN -0.09
- BEAM -0.04
- Stochastic Oscillator
- KN 24.48
- BEAM 67.05
About KN Knowles Corporation
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.